BBS2 and neuroblastoma: We also found that FAK silencing in BE(2)-C cells suppressed tumorigenesis and metastasis in vivo. Furthermore, using an intrasplenic murine model and bioluminescence imaging system, we confirmed that treatment with Y15, a FAK inhibitor, blocks BBS-induced neuroblastoma growth and liver metastases in vivo.